Aerosol Delivery Through an Adult High-Flow Nasal Cannula Circuit Using Low-Flow Oxygen

References

1. 1.↵
   1. Nedel WL,
   2. Deutschendorf C,
   3. Rodrigues Filho EM

   . High-flow nasal cannula in critically ill subjects with or at risk for respiratory failure: a systematic review and meta-analysis. Respir Care 2017;62(1):123–132.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Sim M,
   2. Dean P,
   3. Kinsella J,
   4. Black R,
   5. Carter R,
   6. Hughes M

   . Performance of oxygen delivery devices when the breathing pattern of respiratory failure is simulated. Anaesthesia 2008;63(9):938–940.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Papazian L,
   2. Corley A,
   3. Hess D,
   4. Fraser JF,
   5. Frat J-P,
   6. Guitton C,
   7. et al

   . Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review. Intensive Care Med 2016;42(9):1336–1349.

   OpenUrl
4. 4.↵
   1. Weg JG,
   2. Haas CF

   . Long-term oxygen therapy for COPD: improving longevity and quality of life in hypoxemic patients. Postgrad Med 1998;103(4):143–155.

   OpenUrlPubMed
5. 5.↵
   1. Gotera C,
   2. Lobato SD,
   3. Pinto T,
   4. Winck J

   . Clinical evidence on high flow oxygen therapy and active humidification in adults. Rev Port Pneumol 2013;19(5):217–227.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Chatila W,
   2. Nugent T,
   3. Vance G,
   4. Gaughan J,
   5. Criner GJ

   . The effects of high-flow vs low-flow oxygen on exercise in advanced obstructive airways disease. Chest 2004;126(4):1108–1115.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Ward JJ

   . High-flow oxygen administration by nasal cannula for adult and perinatal patients. Respir Care 2013;58(1):98–122.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Bräunlich J,
   2. Beyer D,
   3. Mai D,
   4. Hammerschmidt S,
   5. Seyfarth H-J,
   6. Wirtz H

   . Effects of nasal high flow on ventilation in volunteers, COPD and idiopathic pulmonary fibrosis patients. Respiration 2013;85(4):319–325.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Lee CC,
   2. Mankodi D,
   3. Shaharyar S,
   4. Ravindranathan S,
   5. Danckers M,
   6. Herscovici P,
   7. et al

   . High flow nasal cannula versus conventional oxygen therapy and non-invasive ventilation in adults with acute hypoxemic respiratory failure: a systematic review. Respir Med 2016;121:100–108.

   OpenUrl
10. 10.↵
    1. Bräunlich J,
    2. Köhler M,
    3. Wirtz H

    . Nasal high flow improves ventilation in patients with COPD. Int J Chron Obstruct Pulmon Dis 2016;11:1077–1085.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Tian G,
    2. Hindle M,
    3. Longest PW

    . Targeted lung delivery of nasally administered aerosols. Aerosol Sci Technol 2014;48(4):434–449.

    OpenUrl
12. 12.↵
    1. Frat J-P,
    2. Thille AW,
    3. Mercat A,
    4. Girault C,
    5. Ragot S,
    6. Perbet S,
    7. et al

    . High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med 2015;372(23):2185–2196.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Abdelrahim M,
    2. Plant P,
    3. Chrystyn H

    . The relative lung and systemic bioavailability of terbutaline following nebulisation in non-invasively ventilated patients. Int J Pharm 2011;420(2):313–318.

    OpenUrlPubMed
14. 14.↵
    1. Sztrymf B,
    2. Messika J,
    3. Bertrand F,
    4. Hurel D,
    5. Leon R,
    6. Dreyfuss D,
    7. et al

    . Beneficial effects of humidified high flow nasal oxygen in critical care patients: a prospective pilot study. Intensive Care Med 2011;37(11):1780–1786.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Hindle M,
    2. Chrystyn H

    . Determination of the relative bioavailability of salbutamol to the lung following inhalation. Br J Clin Pharmacol 1992;34(4):311–315.

    OpenUrlPubMedWeb of Science
16. 16.↵
    1. ElHansy MHE,
    2. Boules ME,
    3. El-Essawy AFM,
    4. Al-Kholy MB,
    5. Abdelrahman MM,
    6. Said ASA,
    7. et al

    . Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation. Pulm Pharmacol Ther 2017;45:159–163.

    OpenUrl
17. 17.↵
    1. Rabea H,
    2. Ali AMA,
    3. Salah Eldin R,
    4. Abdelrahman MM,
    5. Said ASA,
    6. Abdelrahim ME

    . Modelling of in-vitro and in-vivo performance of aerosol emitted from different vibrating mesh nebulisers in non-invasive ventilation circuit. Eur J Pharm Sci 2017;97:182–191.

    OpenUrl
18. 18.↵
    1. Teixeira C,
    2. Savi A,
    3. Tonietto TF

    . Influence of FIO₂ on PaCO₂ during noninvasive ventilation in patients with COPD. Respir Care 2014;59(7):e106–e107.

    OpenUrlFREE Full Text
19. 19.↵
    1. Réminiac F,
    2. Vecellio L,
    3. Heuzé-Vourc'h N,
    4. Petitcollin A,
    5. Respaud R,
    6. Cabrera M,
    7. et al

    . Aerosol therapy in adults receiving high flow nasal cannula oxygen therapy. J Aerosol Med Pulm Drug Deliv 2016;29(2):134–141.

    OpenUrl
20. 20.↵
    1. Chrystyn H

    . Methods to identify drug deposition in the lungs following inhalation. Br J Clin Pharmacol 2001;51(4):289–299.

    OpenUrlPubMed
21. 21.↵
    1. Hassan A,
    2. Salah Eldin R,
    3. Abdelrahman MM,
    4. Abdelrahim ME

    . In-vitro/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation. Exp Lung Res 2017;43(1):19–28.

    OpenUrl
22. 22.↵
    1. Sarhan RM,
    2. Elberry AA,
    3. Abdelwahab NS,
    4. Rabea H,
    5. Salem MN,
    6. Abdelrahim MEA

    . Effect of a nebulizer holding chamber on aerosol delivery. Respir Care 2018;63(9):1125–1131.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Longest PW,
    2. Tian G,
    3. Hindle M

    . Improving the lung delivery of nasally administered aerosols during noninvasive ventilation: an application of enhanced condensational growth (ECG). J Aerosol Med Pulm Drug Deliv 2011;24(2):103–118.

    OpenUrlPubMed
24. 24.↵
    1. Harb HS,
    2. Elberry AA,
    3. Rabea H,
    4. Fathy M,
    5. Abdelrahim MEA

    . Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? J Drug Deliv Sci Technol 2017;40:28–34.

    OpenUrl
25. 25.↵
    1. Golshahi L,
    2. Longest PW,
    3. Azimi M,
    4. Syed A,
    5. Hindle M

    . Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy. Respir Care 2014;59(10):1476–1486.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Madney YM,
    2. Fathy M,
    3. Elberry AA,
    4. Rabea H,
    5. Abdelrahim MEA

    . Nebulizers and spacers for aerosol delivery through adult nasal cannula at low oxygen flow rate: an in-vitro study. J Drug Deliv Sci Technol 2017;39:260–65.

    OpenUrl
27. 27.↵
    1. Spoletini G,
    2. Alotaibi M,
    3. Blasi F,
    4. Hill NS

    . Heated humidified high-flow nasal oxygen in adults. Chest 2015;148(1):253–261.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Quraishi M,
    2. Jones N,
    3. Mason J

    . The nasal delivery of drugs. Clin Otolaryngol Allied Sci 1997;22(4):289–301.

    OpenUrl
29. 29.↵
    1. Golshahi L,
    2. Tian G,
    3. Azimi M,
    4. Son Y-J,
    5. Walenga R,
    6. Longest PW,
    7. et al

    . The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy. Pharm Res 2013;30(11):2917–2930.

    OpenUrlPubMed
30. 30.↵
    1. Hess DR

    . Aerosol therapy during noninvasive ventilation or high-flow nasal cannula. Respir Care 2015;60(6):880–893.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Edwards L,
    2. Perrin K,
    3. Williams M,
    4. Weatherall M,
    5. Beasley R

    . Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Emerg Med J 2012;29(11):894–898.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Austin MA,
    2. Wills KE,
    3. Blizzard L,
    4. Walters EH,
    5. Wood-Baker R

    . Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: a randomised controlled trial. BMJ 2010;341:c5462.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Pilcher J,
    2. Weatherall M,
    3. Perrin K,
    4. Beasley R

    . Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Expert Rev Respir Med 2015;9(3):287–293.

    OpenUrl
34. 34.↵
    1. Rea H,
    2. McAuley S,
    3. Jayaram L,
    4. Garrett J,
    5. Hockey H,
    6. Storey L,
    7. et al

    . The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104(4):525–533.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Berlinski A

    . Pediatric aerosol therapy. Respir Care 2017;62(6):662–677.

    OpenUrlAbstract/FREE Full Text
36. 36.↵
    1. Nishimura M

    . High-flow nasal cannula oxygen therapy in adults: physiological benefits, indication, clinical benefits, and adverse effects. Respir Care 2016;61(4):529–541.

    OpenUrlAbstract/FREE Full Text
37. 37.
    1. Abdelrahim ME,
    2. Plant P,
    3. Chrystyn H

    . In-vitro characterisation of the nebulised dose during non-invasive ventilation. J Pharm Pharmacol 2010;62(8):966–972.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. ElHansy MHE,
    2. Boules ME,
    3. Farid H,
    4. Chrystyn H,
    5. El-Maraghi SK,
    6. Al-Kholy MB,
    7. et al

    . In vitro aerodynamic characteristics of aerosol delivered from different inhalation methods in mechanical ventilation. Pharm Dev Technol 2017;22(6):844–849.

    OpenUrl
39. 39.↵
    1. Mohsen M,
    2. Elberry AE,
    3. Salah Eldin A,
    4. Hussein RR,
    5. Abdelrahim EM

    . Effects of Heat and Humidification on Aerosol Delivery during Auto-CPAP noninvasive Ventilation. Archives of Pulmonology and Respiratory Care 2017;3(1):11–15.

    OpenUrl
40. 40.↵
    1. Harb HS,
    2. Elberry AA,
    3. Rabea H,
    4. Fathy M,
    5. Abdelrahim MEA

    . Is Combihaler usable for aerosol delivery in single limb non-invasive mechanical ventilation? J Drug Deliv Sci Technol 2017;40:28–34.

    OpenUrl
41. 41.
    1. Hassan A,
    2. Rabea H,
    3. Hussein RRS,
    4. Salah Eldin R,
    5. Abdelrahman MM,
    6. Said ASA,
    7. et al

    . In-vitro Characterization of the Aerosolized Dose During Non-Invasive Automatic Continuous Positive Airway Pressure Ventilation. Pulm Ther 2016;2(1):115–126.

    OpenUrl
42. 42.↵
    1. Hassan A,
    2. Salah Eldin R,
    3. Abdelrahman MM,
    4. Abdelrahim ME

    . In-vitro/in-vivo comparison of inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during non-invasive ventilation. Exp Lung Res 2017;43(1):19–28.

    OpenUrl
43. 43.↵
    1. Saeed H,
    2. Ali AMA,
    3. Elberry AA,
    4. Salah Eldin A,
    5. Rabea H,
    6. Abdelrahim MEA

    . Modeling and optimization of nebulizers' performance in non-invasive ventilation using different fill volumes: comparative study between vibrating mesh and jet nebulizers. Pulm Pharmacol Ther 2018:(in press).
44. 44.↵
    1. Saeed H,
    2. Mohsen M,
    3. Salah Eldin A,
    4. Elberry AA,
    5. Abdelwahab NS,
    6. Hussein RRS,
    7. et al

    . Effects of fill volume and humidification on aerosol delivery during single limb non-invasive ventilation. Respir Care 2018;(In Press).
45. 45.↵
    1. Hussein RRS,
    2. M. A. Ali A,
    3. Salem HF,
    4. Abdelrahman MM,
    5. Said ASA,
    6. Abdelrahim MEA

    . In vitro/in vivo correlation and modeling of emitted dose and lung deposition of inhaled salbutamol from metered dose inhalers with different types of spacers in noninvasively ventilated patients. Pharm Dev Technol 2017;22(7):871–880.

    OpenUrl
46. 46.
    1. Sarhan RM,
    2. Elberry AA,
    3. Abdelwahab NS,
    4. Rabea H,
    5. Salem MN,
    6. Abdelrahim MEA

    . The effect of holding chamber, as add on device for nebulizers, on aerosol delivery. Respir Care 2018;(In Press).
47. 47.↵
    1. Boukhettala N,
    2. Porée T,
    3. Diot P,
    4. Vecellio L

    . In vitro performance of spacers for aerosol delivery during adult mechanical ventilation. J Aerosol Med Pulm Drug Deliv 2015;28(2):130–136.

    OpenUrlPubMed
48. 48.↵
    1. Golshahi L,
    2. Longest PW,
    3. Azimi M,
    4. Syed A,
    5. Hindle M

    . Intermittent aerosol delivery to the lungs during high-flow nasal cannula therapy. Respir Care 2014;59(10):1476–1486.

    OpenUrlAbstract/FREE Full Text
49. 49.
    1. Golshahi L,
    2. Tian G,
    3. Azimi M,
    4. Son Y-J,
    5. Walenga R,
    6. Longest PW,
    7. et al

    . The use of condensational growth methods for efficient drug delivery to the lungs during noninvasive ventilation high flow therapy. Pharm Res 2013;30(11):2917–2930.

    OpenUrlPubMed
50. 50.
    1. Berlinski A

    . Pediatric Aerosol Therapy. Respir Care 2017;62(6):662–677.

    OpenUrlAbstract/FREE Full Text
51. 51.
    1. Rea H,
    2. McAuley S,
    3. Jayaram L,
    4. Garrett J,
    5. Hockey H,
    6. Storey L,
    7. et al

    . The clinical utility of long-term humidification therapy in chronic airway disease. Respir Med 2010;104(4):525–533.

    OpenUrlCrossRefPubMed
52. 52.
    1. Spoletini G,
    2. Alotaibi M,
    3. Blasi F,
    4. Hill NS

    . Heated humidified high-flow nasal oxygen in adults. Chest 2015;148(1):253–261.

    OpenUrlCrossRefPubMed
53. 53.
    1. Quraishi M,
    2. Jones N,
    3. Mason J

    . The nasal delivery of drugs. Clin Otolaryngol Allied Sci 1997;22(4):289–301.

    OpenUrl
54. 54.
    1. Edwards L,
    2. Perrin K,
    3. Williams M,
    4. Weatherall M,
    5. Beasley R

    . Randomised controlled crossover trial of the effect on PtCO2 of oxygen-driven versus air-driven nebulisers in severe chronic obstructive pulmonary disease. Emerg Med J 2012;29(11):894–898.

    OpenUrlAbstract/FREE Full Text
55. 55.
    1. Austin MA,
    2. Wills KE,
    3. Blizzard L,
    4. Walters EH,
    5. Wood-Baker R

    . Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: Randomised controlled trial. Bmj 2010;341:c5462.

    OpenUrlAbstract/FREE Full Text
56. 56.
    1. Pilcher J,
    2. Weatherall M,
    3. Perrin K,
    4. Beasley R

    . Oxygen therapy in acute exacerbations of chronic obstructive pulmonary disease. Expert Rev Respir Med 2015;9(3):287–293.

    OpenUrl